 SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 GLOBE NEWSWIRE -- Assembly Biosciences, Inc. Nasdaq: ASMB, a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus HBV and diseases associated with the microbiome, today announced a grant of stock options to a new employee to purchase 6,520 shares of the Companys common stock with an exercise price of 14.75 per share, the closing price of Assemblys common stock on November 2, 2020. The stock options were granted as a material inducement to the new employee to accept the Companys offer of employment. 